NETRIS Pharma Announces Clinical Trial Collaboration Agreement with MSD to Evaluate NP137 in Combination with KEYTRUDA® (Pembrolizumab) in Advanced Uterine and Cervical Tumors

NEXT STORY
ObsEva Announces First Quarter 2020 Financial Results and Business Update
PREV STORY
Algenex advances insect-based vaccine production technology in human health
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Nunzia Pharmaceutical Corporation (OTC: NUNZ), an Emerging Leader in Innovative Pharmaceutical and Nutraceuticals, is Now Offering a Patented Blood Warmer Through Nunzia’s Medical Supply Division. 8K Filed 08/05/2021

author_avatar
NASDAQ Market News

FormFactor, Inc. Reports 2020 Fourth Quarter Results

author_avatar
NASDAQ Market News

Allogene Therapeutics, in Collaboration with Servier, to Present Initial Results from its Phase 1 ALPHA Study of ALLO-501 AlloCAR T™ Therapy in Relapsed/Refractory Non-Hodgkin Lymphoma at the American Society of Clinical Oncology

author_avatar
NASDAQ Market News